Holen Sie sich die Stockscreener-App
1.77
2.31%
0.04
Schlusskurs vom Vortag:
$1.73
Offen:
$1.72
24-Stunden-Volumen:
401.71K
Relative Volume:
1.96
Marktkapitalisierung:
$44.67M
Einnahmen:
$20.46M
Nettoeinkommen (Verlust:
$-4.85M
KGV:
-3.6122
EPS:
-0.49
Netto-Cashflow:
$-6.23M
1W Leistung:
+14.56%
1M Leistung:
-9.69%
6M Leistung:
+12.03%
1J Leistung:
+29.20%
1-Tages-Spanne:
$1.61
$1.7845
1-Wochen-Bereich:
$1.49
$1.88
52-Wochen-Spanne:
$1.18
$2.6499
Icad Inc Stock (ICAD) Company Profile
Firmenname
Icad Inc
Sektor
Branche
Telefon
603-882-5200
Adresse
98 SPIT BROOK ROAD, SUITE 100, NASHUA, NH
Vergleichen Sie ICAD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICAD
Icad Inc
|
1.77 | 44.67M | 20.46M | -4.85M | -6.23M | -0.49 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Icad Inc Stock (ICAD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-01-18 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-22 | Eingeleitet | Guggenheim | Buy |
| 2021-03-23 | Eingeleitet | BTIG Research | Buy |
| 2021-02-26 | Eingeleitet | Oppenheimer | Outperform |
| 2021-01-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-12-03 | Eingeleitet | B. Riley Securities | Buy |
| 2020-02-05 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-01-09 | Eingeleitet | Lake Street | Buy |
| 2008-12-09 | Bestätigt | Canaccord Adams | Buy |
| 2008-08-01 | Bestätigt | MDB Capital Group | Buy |
| 2008-05-14 | Bestätigt | Canaccord Adams | Buy |
| 2008-02-14 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
| 2007-01-24 | Bestätigt | Dawson James | Speculative Buy |
Alle ansehen
Icad Inc Aktie (ICAD) Neueste Nachrichten
iCAD Advances Fight Against Breast Cancer with FDA-cleared, - GlobeNewswire
iCAD's New AI Cancer Detection System Boosts Accuracy by 22%, Partners with Cascaid Health | ICAD Stock News - StockTitan
U.S. Computer-Aided Detection (CAD) Market Future Business - openPR
Computer Aided Detection (CAD) Market: Expected Positive - openPR
Need To Know: Analysts Just Made A Substantial Cut To Their iCAD, Inc. (NASDAQ:ICAD) Estimates - Yahoo Finance
iCAD Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
iCAD, Inc. (NASDAQ:ICAD) Q3 2024 Earnings Call Transcript - Insider Monkey
iCAD (NASDAQ:ICAD) Rating Lowered to “Sell” at StockNews.com - Defense World
ICAD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Earnings call: iCAD reports steady growth with SaaS transition By Investing.com - Investing.com Canada
Q3 2024 ICAD Inc Earnings Call - Cbainfo
iCad Inc. (ICAD) Quarterly 10-Q Report - Quartzy
Icad: Q3 Earnings Snapshot - New Haven Register
iCAD (NASDAQ:ICAD) Shares Pass Above 200-Day Moving AverageWhat's Next? - MarketBeat
icad Inc (ICAD) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Strategic Shifts - GuruFocus.com
iCAD, Inc. Reports Growth in ARR and Revenue - TipRanks
iCAD reports Q3 adjusted EPS (7c), consensus (8c) - TipRanks
iCAD Inc Reports Q3 2024 Revenue of $4.2 Million, EPS Loss of $0 - GuruFocus.com
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024 - GlobeNewswire
iCAD Q3 Revenue Grows 4%, Secures FDA Clearance for Enhanced Cancer Detection Tech | ICAD Stock News - StockTitan
iCAD AI breast cancer detection tool gains FDA approval By Investing.com - Investing.com Australia
FDA clears AI-powered breast cancer detection tech from iCad - Mass Device
iCAD announces ProFound Detection for DBT received clearance from FDA - TipRanks
iCAD's ProFound Detection Version 4.0 Gets FDA Clearance - Imaging Technology News
iCAD AI breast cancer detection tool gains FDA approval - Investing.com
iCAD's ProFound Detection Version 4.0 Gains FDA Clearance - GlobeNewswire
iCAD's AI Cancer Detection Gets FDA Nod, Shows 60% Better Accuracy in Key Areas | ICAD Stock News - StockTitan
iCAD, Inc. (NASDAQ:ICAD) Looks Just Right With A 47% Price Jump - Simply Wall St
Volpara, DHA Sign Deal to Modernize Mammography Services - Imaging Technology News
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference - GlobeNewswire
iCAD to Present at Craig-Hallum Conference: AI Healthcare Leader Meets Institutional Investors | ICAD Stock News - StockTitan
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024 - GlobeNewswire
icad (ICAD) Cash, Cash Equivalents, Marketable Securities : $20.35 Mil (As of Jun. 2024) - GuruFocus.com
Computer Aided Detection Market Is Booming Worldwide 2024-2031 - openPR
iCAD (NASDAQ:ICAD) Share Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat
iCAD (NASDAQ:ICAD) Share Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
ICAD, Inc. (ICAD): A Bull Case Theory - Insider Monkey
3 US Penny Stocks With Market Caps At Least $40M To Watch - Simply Wall St
iCAD (NASDAQ:ICAD) adds US$15m to market cap in the past 7 days, though investors from three years ago are still down 82% - Simply Wall St
iCAD (NASDAQ:ICAD) Stock Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
iCAD to Participate in the LD Micro Main Event XVII - The Sudbury Star
icad Inc (ICAD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts - Yahoo Finance
Breast Cancer Brachytherapy Market Growth Report | Elekta, Varian Medical Systems, ICAD, Hologic, Cianna Medical - Times-BD24
iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024 - GlobeNewswire
New Research Finds iCAD's ProFound AI Risk for Digital Breast Tomosynthesis is 2.4x More Accurate than Traditional Lifetime Risk Models - Barchart
Siemens Healthineers Receives FDA Premarket Approval for 3D Portion of Mammography System - Imaging Technology News
iCAD (NASDAQ:ICAD) Stock Price Passes Above 200 Day Moving Average of $1.50 - Defense World
Intraoperative Radiation Therapy Market Present Scenario of Manufacturers – ZEISS Group, iCAD, IntraOp Medical Corporation, Ariane Medical Systems – Cauverynews - Cauverynews
Finanzdaten der Icad Inc-Aktie (ICAD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):